Getting the ATTR-CM Care You Need

Black people have a particularly high risk of transthyretin cardiac amyloidosis (ATTR-CM)external link, opens in a new tab, an incurable condition that can lead to heart failure. And, according to a 2024 studyexternal link, opens in a new tab published in JACC: CardioOncology, they often develop more aggressive disease and get diagnosed later in its course. That’s a dangerous combination. ATTR-CM patients benefit most from early treatment, because currently available medications only slow the disease’s progress—they can’t fix damage already done. Learn more about the disease’s impact on Black patients and why it’s important to advocate for yourself.